Marwah Medicine

Artboard 3
Medical, Medicine classes, NEET PG

3 ways to overcome afternoon drowsiness for Doctors preparing

For NEET PG entrance / NEXT examination While it is common for small children to take afternoon naps, we grown-ups cannot afford the same luxury. Research shows it is quite natural to experience drowsiness and lethargy during in the afternoon, around 8 hours after waking up. Drinking an extra cup of coffee may sound tempting, but it is certainly not the healthiest way to stay awake. While these hacks may help you temporarily ward off afternoon drowsiness, you may want to ensure there’s no underlying medical condition at play. Most young people don’t realize that this drowsiness can be symptom of iron or nutrient deficiency, insulin resistance or obstructive sleep apnea. No harm or shame in getting yourself evaluated rather than using quack remedies to ward off sleepiness. Today, I’m going to share with you 3 healthy ways to combat afternoon drowsiness and re-energize your body. Take a Power Nap Another great way to combat afternoon sluggishness is take a quick 20-minute power nap. Research proves that 20 minutes of afternoon sleep is way more restful than 20 minutes of extra sleep in the morning. Don’t look at FaceBook or Whatsapp during lunch which we normally do. That just saps our brain further. Say No to Canteen Food which is greasy and unhealthy. Either cook your self or order from a healthy restaurant. Processed food digests quickly, messes with your blood sugar levels, and leads to low energy levels. As someone struggling with afternoon sluggishness, you should avoid processed food at all costs. Instead opt for healthy, energizing meals which are rich in iron, lean protein and complex carbohydrates, for example: leafy green vegetables, lean meat, whole grains etc.

5 way to overcome
Medicine, Medicine classes

5 Ways to Overcome the Fear of Failing in Exams

Have you ever been so afraid of failing at an exam that you just skipped it altogether? Fear of Failure is paralyzing. It leads to missed opportunities, inactivity, and low self-esteem. But don’t let the fear of failing an exam take over your life. Here are 5 proven ways to help you overcome this fear and create a healthier mindset. Identify the Root Cause of your Fear Examine your negative beliefs. Where does your fear of exams originate from? Take some time, sit down and introspect. Ask yourself the tough questions. Is the fear legit? How did you develop this fear? Is it making your life better or worse? And finally, what is the real cause behind your fear of failing exams? Once you figure out the real reason behind your fear of failure, you’ll realize that it sounds silly and you’ve fretting over nothing. Examining your negative beliefs is not easy, and requires a lot of courage. But it is definitely worth doing if you want live your life to the fullest. Remind yourself that Failure is Temporary Failure may feel permanent but it is nothing more than a temporary setback. The consequences of failure are never as bad as you imagine. Always remember that failing an exam is nothing more than a road bump. It is not the end of your life. Instead try to look at failure as feedback. When you fail an exam, you get to analyze where you went wrong which helps you prepare better for the next attempt. Overcome all-or-nothing Mindset All-or-nothing thinking or perfectionism is away thinking that pushes you towards unrealistic goals. Perfectionism is often seen as a strength, but being too much of a perfectionist can sometimes lead to self-defeating thought patterns. Too much perfectionism may lead to anxiety, fear of failure, and low self-esteem among other mental health issues. If you’re struggling with perfectionism, start with slowly challenging your behavior. List down things you believe should be done perfectly. Next write the reasons why you believe that activity must be perfect. And at last, write down the consequences if things don’t turn out as planned. When you write things down, you’ll be able to see through your negative beliefs and tackle them with better understanding. Work towards building a Healthy Self-Esteem When you have healthy self-esteem, you don’t see failure as a dead end but as a stepping stone to success. Work of shifting your perspective. Failure is inevitable. Even the most brilliant brains have faced failure. And who said failure is a bad thing? Failure is actually a blessing in disguise. Failure, not a success, teaches you lessons worth learning Exams. Welcome failure. Befriend your fears. Only then can you overcome them. Start Exercising and Meditating Join a gym. Go on a run. Work-out. Exercise releases endorphins which are natural painkillers, and help you combat stress in a much healthier way. Meditation is a great way to calm your mind and prepare yourself to face your fears with courage. When you meditate, you free your mind from anxious thoughts and become much more aware of yourself and your surroundings. Your breathing slows down, your mind stops racing and your pulse rate drops to a healthier level.

Medical, Medicine classes

Making an Effective Study Plan

Some tips to help you A study plan isn’t just a timetable, it’s much more than that. It details study goals, courses or syllabus to cover, time to be devoted to each, course material to study from, revision plans, tools to test your preparation, and more. Drawing a study plan helps you organize your time and thoughts better. It can help you stay focused, increase productivity, avoid mismanagement, and achieve your goals faster. Making an effective study plan can sound challenging. However, with some good planning and prioritization, you can come up with a handy study plan that enables you to accomplish your academic goals in an organized way. Well, before you start working on creating your study timetable, it is important to be aware of your learning style and your study potential. Also, you should consider and jot down all factors that can affect your study plan. We have listed below a few tricks and tips that can help you create an effective study plan. One way to make sure you get the best results in managing your study plan is to first collect all study material that you would need. You can collate your entire syllabus together from a reputed online study program provider and then use it effectively as per your need. Also, any books, class notes, or additional study material you may need, you should procure beforehand. Self evaluates and try to understand when and at what time of the day you are able to concentrate the most. This will help you to plan your daily routine in the best possible way. It is advisable to study during the daytime as all entrance exams are conducted during the day. If you are a night owl, try to slowly adapt and shift your study schedule to mornings as you wouldn’t want to be lethargic and unfocused during the actual exam. A handy study timetable consists of the variables like date and time with days of the week. You can hand draw a grid to prioritize your study schedule. Use colored highlighters to differentiate between weak and strong subjects, short and long subjects, etc. Divide your available time during a week into study blocks and then assign those blocks to a subject. This enables you to manage your time wisely without constantly checking. Start with 2 hours a day and then increase it gradually. This is an ideal way to go about it. The study is inevitably your key priority. However, it is important to take rest. To stay fresh and ensure complete concentration, it is advisable to take a power nap for an hour during the afternoon, after lunch. Pursuing your study schedule on a regular basis enables you to meet your academic goals. But, it is also vital to understand your requirements and make amendments accordingly. Once, you are aware that you understand a specific subject and need less time to study it than you should move on to another subject. By doing this, you can balance your study in a planned way. Creating your study plan in an easy-to-understand manner is another way to give a balanced approach to all subjects. The right way to go about it is to color-code all subjects so that you know which subject is easier and requires less study time and which subject is tougher and needs more study time. Prioritizing the subjects and courses, you need to study for within a certain amount of time is harder than you think. Therefore, it is advisable to finish one subject in a week and then move towards the second one instead of studying all at one time. Revision is the most important aspect of your study. During the first revision, it is better to revise two subjects in a day as that makes more sense. Following these tips and tricks, will surely help you achieve your academic goals. So, start creating your study timetable if you are looking to crack UG or PG entrance exams.

Medical, Medicine classes

How to effectively use the Rapid revision program to increase your Strike rate?

Imagine you are a month away from the exam day, your social media feed is full of stressful comments and you feel uncomfortable no matter what you do. Self-doubt creeps up on you. You start questioning your preparation, doubting whether you are on the right track and feeling as if everyone’s ahead of you in the game. You feel as if you are being left behind. STOP! It’s time to go into INTERNET DARKNESS MODE and stop the internet feed from taking over your brain and demeaning your efforts. It is now time for Rapid Revision and nothing is going to stop you from getting to your target. Complete the entire Internal Medicine RR series in 3 days@ 5hours. For each session minimum continuous sitting advised is of 3-4 hours. This is in keeping with the exam duration i.e. 3 hours plus the 15-30 minutes time before exam, when you reach the exam hall and wait for the exam to start. Keeping your study sessions of similar duration will help you build stamina for sitting that long and being able to concentrate. If you feel fatigue in back muscles and strain in eye muscles after 2 hours of continuous sitting in front of the laptop it means that your physical fitness is not up to the mark. Use the months until the exam to practice and improve. Write down summary of each topic in max five points. Keep a separate 50-page register for this. Focus especially on comparisons, for example multifocal atrial tachycardia versus Atrial Fibrillation, Multiple Sclerosis versus Neuromyelitis Optica. The combination of Audio-visual stimulus along with quick jotting down of important points will prep up your neo-cortex with lots of information to be deployed in the final battle in the examination. The entire list of antibodies mentioned in the Rheumatology section have to be crammed up straight, as it does not need much understanding and if asked during the exam, your eyes should be hunting for the correct option. Some path slides have been incorporated to cover the integrated topics. For those where the path slides are mentioned make a note in the register and do those topics from Pathology RR as well on the same day. Even if you’ve to compromise on a few hours sleep, try to do those topics on the same day, as it will increase your retention of these integrated topics. On the fourth day, the following five lectures must be done at 1.5 X from the main app in the last month before the exam. Questions are always asked from these topics in any exam anywhere in the world. It will take less than half a day and the rest of the day can be dedicated to MCQ of multiple topics. Electrolyte imbalance (Kidney first lecture) Renal Tubular acidosis (Kidney) Epilepsy and EEG (neuro First lecture), AIDS (Last lectures in App) ECG and Arrythmias Keep in touch with your family. A comforting voice can change your mood and remind you that you are doing it to make your parents proud of your achievements. Focus on the positives. Do something apart from furiously scrolling Instagram or Facebook. This is important for your sanity. Those who post every hour on Facebook may be much less prepared than you are and only showing off. Never Show off and be humble. Best Wishes for the Final Battle. You can do this.

Medical, Medicine classes

Hardships in MEDICAL FIELD during COVID POSTINGS

Tired of all the expectations! Doctors are not just burdened with work but also with a ton of expectations, from patients, their families and society as well. You don’t get to begin your day in a brilliant coloured corporate boardroom hi-fiving a good-looking colleague. Rather you usually begin and even end your day talking to a gloomy looking patient telling you his sad story. Very often you are further burdened with the HOD asking you to run some random errands. Most of your days are spent running between the OPD and the IPD, trying to manage the never ending stream of patients. A regular day starts at 8 am with just a simple toast and tea. Breakfast is a luxury you haven’t had time for several years. Sometimes the days begin even earlier than 8 am or the long night shift never ends. Well, let’s face it; we have all gone through the daily grind of being a doctor, faced our fair share of expectations, and powered through the rough days. Mostly we still manage to come out of all this smiling. First of all, becoming a doctor is not a joke and requires extreme mental and physical fitness. Ordinary people can’t hold their bladder for 2 hours. Ever seen the queue outside the toilet in the 2-hour Delhi Hyderabad flight, while you hold it for 10 hours in the operation theatre? So relax, you are a class apart. You’re the one delivers a baby aboard an indigo flight while the mindless airline staff takes selfies with a preterm 1.5Kg baby without ensuring basic hygiene. Hence, worsening the risk for COVID-19 transmission. So, the first message of this write up is: BEING a DOCTOR is not a JOKE and these internet educated people are sissies, simply looking for some masala and sympathy. For them Homeopathy is good despite no evidence of its efficacy and inspite of the fact that Lancet called it the biggest scam of the century. These dumb heads would rather believe a smooth-talking baba than science and evidence. They actually deserve what the government gives them i.e. no hospital beds and no health care. However, in the face of all this frustration and anger we might be feeling, let’s not forget that there is a meaning behind all this. Somebody on this planet has to volunteer and gear up to reduce the misery being spread by politicians and people alike. Like Lord Shiva, someone has to drink the poison and you’re the one doing it. Surrender is not the way. Your HOD may be cumbersome, the consultants selfish and self-absorbed but you mustn’t let these selfish and inferior people force you to give up. You must rise and shine for a bigger purpose and that is to make your mother and country proud. You’re the pillar upholding this ramshackle of a heath infrastructure that is crumbling. While the MLA of your district enjoys a bevy of official cars and a luxurious office, the poor District Medical Officer sits in a non-descript building without any air conditioning, doing so much paper work apart from finishing an OPD of 200 desperate people who have nowhere to go. If these people go to the police station they are beaten and if they go to the politician they fear being murdered. So, they go and vent their frustration at a poor and studious 24-year-old MBBS doctor. Not that you need to take any non-sense, but showing a bit of empathy will surely help you reduce your stress level and remedy the angst of the hostile and low IQ homosapiens. The COVID-19 situation has been a whirlpool of death and equivalent to near extinction. You are one of those brave soldiers who are fortunate enough to have been selected for the mission to defeat the virus. Perhaps, that’s the reason you take all the crap from your seniors, while sacrificing your personal well being, going to duty in a PPE kit on an empty stomach. This is not a joke. None of the non-medicos have the attitude, physical and mental capability required to wear this battle gear. You’re a class apart, a cut above the rest. You’re a doctor who must not accept nonsense. Your beliefs are rooted in giving it back when the situation demands. Instead of being angry at a poor patient, make the pseudo intellectuals cry. This is a flat line ECG. It takes 5 and half years to understand the basics of this. And yet, a 12th fail’s relatives barge in only to ask you to take body temperature as body is warm. They have no shame in beating the doctor up and in damaging hospital property. In such an event, all legal provisions must be used and non bailable warrants issued against the culprits. To cut the long story short, the take home message for a young and dashing doctor is: You’re born to drink poison and reduce the suffering of the poor and downtrodden. You are mentally and physically superior. Under any circumstances don’t try to hurt your-self. Your parents and loved ones are more important than everything else. Talk to your parents daily, even if it’s only for a couple of minutes after the end of your shift. Don’t rush during the removal of your PPE kit. Ensure that you use the sanitizer liberally and allow it to air dry. Thanks for reading all my rambling in this crazy time. Love you all! Dr. Marwah

Medical, Medicine, Medicine classes, NEET PG

Dr. Marwah Live: Best YouTube channel for budding doctors

Medical science is one of the most widespread forms of education in the world, where the bests emerge towards becoming doctors, the saviors of lives. While it is one of the most desired professions in the world, it is also, without a doubt, one of the most difficult professions to get into.  Honestly, why wouldn’t it be when people often refer to them as mortal Gods or entrust them with all their heart for saving hundreds of lives. Therefore, the course of MBBS for budding doctors and the subsequent entrance for their PG courses are extremely challenging, to say the least. However, they need not worry, because there are materials available online that can be the live-savers of the saviors.  While there are hundreds of books available, with each weighing about a ton each, there are also interactive live sessions available online, and they are as important for the real-life experience as books are for knowledge. One such platform that helps the budding doctors and PG aspirants to further success in their careers is Dr. Marwah Live, a YouTube Channel, designed by Dr. Deepak Marwah, to aid the students to learn the concepts of the field of medical science, through live sessions, where he gives real-life visualization of the world of medicine. His sessions are moderately long, that do not bore the students with few hours of monotonous information, making their brain capacities reduce and cause mental fatigue. Dr. Deepak Marwah is a widely known academician and a clinician. He has been teaching young medical students, who are the flag-bearers of the medical science of the next generation. He trains them for their Undergraduate examination concepts and trains them for post-graduation entrances. An alumnus of the Maulana Azad Medical College in Delhi, he has been involved with academics for the last 15 years. With over 45 thousand Subscribers, his channel is one of the most student-friendly channels available in the field of medical science, with lucid lectures that aid the ease of understanding every concept by heart. Although there is no particular day in the week that he uploads the videos or goes a life, they are fairly regular and whenever they come up, it is made sure that they are delivered in the best ways possible. Dr. Marwah not only teaches the concepts of Medical Sciences with ease and depth but also provides live interactive preparatory classes for INICET aspirants, who want to join for Post Graduate (PG) courses in Medical Science, like Doctor of Medicine (MD), Masters of Surgery (MS) and so on. He provides keynotes on how to crack the examinations, increase the strike rate, and score at a level where the candidates can be in a position to choose their Post Graduate Specialization according to their own preference and design their future in the field of medical science, just how they envision it. The eligibility criteria to appear in the INICET examination is that the candidates must have acquired their previous degree and also completed one year of their mandatory rotatory internship and have acquired the certificate for the same.  Once they have qualified for eligibility to sit for the exam, they have to score over the decided cut-off in the INICET exam and then continue with the follow-up procedures for finally being admitted to their preferred specialization in the post-graduate courses of whatever their chosen degree or domain would be. Some of Dr. Marwah’s widely appreciated and viewed videos are: INICET practice Sessions Cardiorenal Syndrome Quick Revision of Internal Medicine Multisystem Inflammatory And so on. Along with these, a series on his YouTube Channel has become hugely impactful on the medical students, for its realistic approach. The series is known as Clinical Scenarios Live stream. In these videos, the real-life scenarios in the medical world are discussed with the viewers. Dr. Deepak Marwah is also very vocal about the balancing of academics and life. He emphasizes the fact that rest and sleep are two very integral parts of life in order to repair and maintain the mind and body and also get rid of the fatigue that our minds may have been affected by due to continuous pressure. He says that according to him, proper rest and sleep are directly proportional to better efficiency in any concerned field. Some of the tips that he gives in order to follow a healthier lifestyle to performing better are: Following a healthy sleep schedule Take breaks in between studying to rest your brain and take a nap Distancing from the intoxication of any kind Being physically active in daily life Besides the importance of sleep and a healthy lifestyle, Dr. Marwah is also vocal about the tips to stay motivated and emotionally healthy while the students are going through a difficult phase of examinations and have to invest a lot of time studying. According to him, psychology identifies four different types of motivation- Extrinsic motivation comes from the outer world, intrinsic motivation comes from within, introjected motivation is the voice inside us that pressurizes us, and identified motivation makes a person knows their purpose and benefits of doing a certain job. To increase motivation, Dr. Marwah suggests the following: Reinforcement Learning: Setting a positive reward for an act or behavior, or a target reached The Ulysses Pact: Planning something and being bound by the plan to perform it. The Self Talk: The internal self-conversations that motivate people to do better. It is visible that Dr. Marwah is not just a wonderful academician, but also an insightful person. The time and effort that he has put into his channel, trying to help students get hold of their dreams, is commendable. His efforts have provided a new direction to the students and helped them score their targets whilst clearing their concepts and thus, it would not be an overstatement to say that his channel is undoubtedly the best platform for budding doctors to grow and learn and open their eyes to an ocean of opportunities lying ahead for them. […]

Medicine classes

Commotio Cordis: When a Blow to the Chest Stops a Heart

The tragic death of Spanish footballer Jesús de Miguel—and the electrical accident every medical student should understand. The moment football stopped Ninety minutes of football. The scoreboard read 2–2. The match between CD Tenerife and FC Andorra was deep into added time on 2 November 2026 when striker Jesús de Miguel chased a loose ball near midfield. Goalkeeper Jesús Owono had raced out to challenge for it. The two collided; reports describe a forceful impact to de Miguel’s chest. He went down, medical staff rushed onto the pitch, and the match was abandoned. This was no longer about a result. De Miguel, 30, was taken to hospital after a reported cardiac arrest. His circulation was reportedly restored during emergency care, but his neurological condition later deteriorated. Tenerife announced his death at 8 a.m. on 3 November. The Spanish football community mourned him with tributes across stadiums. [1–3] Reports citing preliminary forensic findings point to accidental chest trauma; some subsequent reporting specifically raised commotio cordis. The complete forensic record and rhythm documentation have not been made public. It would therefore be inaccurate to call the precise arrhythmic mechanism definitively proved. But the case offers an urgent lesson in how chest trauma can cause sudden cardiac arrest. [2–4] A strange possibility: the heart may be structurally normal Most of us associate sudden cardiac death in an athlete with an abnormal heart: hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, coronary anomalies or an inherited channelopathy. Commotio cordis is different. It is an abrupt, usually ventricular-fibrillation cardiac arrest triggered by nonpenetrating impact over the precordium during a brief electrically vulnerable phase of the cardiac cycle. The classic case has no pre-existing structural heart disease to explain the arrest. [5–7] Think of it this way: the chest receives a mechanical blow, but the catastrophe is primarily electrical. A heart need not rupture, tear or even show major visible damage for a lethal arrhythmia to start. Nor does the person have to be an elite athlete. [5,6] The few milliseconds that matter: why the T wave is the culprit A normal heartbeat is a carefully timed electrical sequence. The QRS complex represents ventricular depolarisation. The T wave represents ventricular repolarisation. During a narrow interval around the early or ascending portion of the T wave, ventricular tissue is particularly vulnerable to a premature electrical disturbance. If a blow arrives directly over the heart at just that moment, sudden myocardial deformation can activate mechanosensitive ion channels. The resulting abnormal current may trigger premature ventricular excitation and degenerate into ventricular fibrillation (VF). This interaction is called mechano-electric coupling. Experimental models demonstrate an especially narrow vulnerable interval, about 15 milliseconds in one well-studied animal model; clinical descriptions commonly refer to a window of roughly 20–40 milliseconds. [6–8] For students: this is closely related to the concept behind the R-on-T phenomenon—a ventricular premature beat falling on the T wave, when repolarisation is vulnerable. In commotio cordis, however, the initiating stimulus is the chest impact; an actual R-on-T tracing is not required to make the clinical diagnosis, and no such tracing has been publicly documented in de Miguel’s case. The correct conceptual chain is: chest impact over the heart → mechanical activation of cardiac tissue during vulnerable repolarisation → VF → loss of cardiac output → collapse. Why is a seemingly ordinary impact dangerous? Three elements must coincide: location, timing and impact characteristics. A blow directly over the precordium is particularly relevant. It has to arrive during a tiny part of the electrical cycle. The shape, speed and compliance of the impacting object can also affect the risk. Baseballs, softballs, lacrosse balls and hockey pucks have featured prominently in published cases, but footballs and player-to-player collisions have also been reported. [5–7] Young athletes are disproportionately represented, partly because a younger chest wall is more compliant. That does not mean adults are immune. Equally, an especially violent collision may create structural thoracic injury—something that demands assessment on its own and must not automatically be labelled classical commotio cordis. [6,8] Sudden cardiac arrest is not the same as a heart attack Here is the viva trap. Cardiac arrest describes the sudden failure of effective circulation. Sudden cardiac death describes a fatal outcome after a cardiac event. Myocardial infarction is injury caused by myocardial ischaemia, usually from coronary artery obstruction. They are not synonyms. In commotio cordis, the initial lethal event is typically VF: the ventricles quiver instead of contracting productively. Cerebral perfusion drops to nearly zero, and the person collapses. Hypoxic-ischaemic brain injury may develop if circulation cannot be restored promptly. An athlete can appear perfectly fit immediately before this happens. [5–7] Could it have been something else? The differential matters A collapse after chest trauma is a clinical emergency, not a retrospective diagnosis from a video. Other possibilities include cardiac contusion with arrhythmia, myocardial or chamber rupture, traumatic coronary injury, tension pneumothorax or major vascular injury. In athletes, a coincidental spontaneous arrhythmia from cardiomyopathy or channelopathy must also be considered. Classical commotio cordis is generally a diagnosis supported by the sequence of precordial impact followed immediately by arrest, ideally a documented ventricular arrhythmia, and assessment excluding significant structural injury or another primary cardiac cause. Where the clinical and forensic records are incomplete, uncertainty should remain explicit. [6,8] At the touchline: what actually saves lives? A player collapses after a blow to the chest. Do not spend the first precious seconds debating whether the blow looked severe enough. If the person is unresponsive and is not breathing normally—or is only gasping—activate the emergency response, begin CPR and send immediately for an automated external defibrillator (AED). In India, call 112 for emergency assistance where available. [5,9] For an adult, deliver high-quality compressions at 100–120 per minute, approximately 5–6 cm deep, allowing full recoil and minimising interruptions. Switch on the AED as soon as it arrives, attach the pads to the bare chest as shown on the diagrams, and follow its prompts; do not delay compressions while preparing the device. If VF or pulseless VT is identified, the […]

Medical, Medicine, Medicine classes

The New 2026 Definition of Myocardial infarction Explained

Type 1,2, 3, 4a 4b 4c and type 5 are outdated now   Based on 2026 Fifth Universal Definition of Myocardial Infarction: Primary, Secondary & Procedure-Related MI Explained For years, every cardiology learner memorized MI as type 1, type 2, type 3, type 4a/4b/4c and type 5. In 2026, that numerical framework was replaced by a simpler clinical classification. The Fifth Universal Definition of Myocardial Infarction now groups MI into primary, secondary and procedure-related MI. The big change: Old numerical labels are replaced by three clinical categories: PRIMARY MI, SECONDARY MI and PROCEDURE-RELATED MI. Why did the definition change? The older type-based system was scientifically useful but became difficult to apply consistently, particularly when ischemia occurred during another acute illness, when the coronary mechanism was not atherothrombosis, or after PCI or cardiac surgery. The 2026 ESC/ACC/AHA/WHF document shifts the emphasis from memorizing numbers to identifying the clinical mechanism. The new three-part MI classification 1. Primary myocardial infarction Primary MI is a spontaneous MI caused by a primary acute coronary pathology. Importantly, it is broader than the old type 1 atherothrombotic concept. It can include acute coronary atherothrombosis as well as spontaneous coronary artery dissection, coronary embolism, coronary vasospasm and certain late stent/graft failures that behave as new coronary disease rather than immediate procedural complications. Think: the coronary artery itself has developed an acute primary problem. 2. Secondary myocardial infarction Secondary MI occurs when another acute condition creates a myocardial oxygen supply-demand imbalance and objective evidence supports infarction. Examples may include profound anemia, severe hypoxemia, shock, sustained tachyarrhythmia or marked hypertension in the appropriate clinical context. The distinction from myocardial injury remains crucial. Troponin elevation alone does not equal MI. There must be evidence that acute myocardial ischemia is responsible for the injury. Think: the heart is suffering because another acute illness has upset oxygen supply versus demand. 3. Procedure-related myocardial infarction Procedure-related MI is an infarction occurring as a complication of a percutaneous or surgical cardiac procedure. The new framework aims to use clinically meaningful, objective criteria rather than maintaining multiple numerical subtypes. The document distinguishes genuine procedure-related MI from isolated biomarker release after a procedure. Think: the infarction is directly linked to a cardiac procedure and has evidence of a coronary complication plus new myocardial damage. So what happened to old Type 3 MI? The term “type 3 MI” has been removed. When sudden cardiac death is believed to be due to MI but biomarker testing is unavailable, the event should be classified using the new clinical framework — primary, secondary or procedure-related — based on the setting and available clinical or post-mortem evidence. What about troponin? Troponin remains central, but the 2026 document sharpens the distinction between myocardial injury and myocardial infarction. Myocardial injury is defined by cardiac troponin above the 99th percentile upper reference limit. Acute injury requires a dynamic rise and/or fall. To diagnose MI, the troponin pattern must be accompanied by evidence of acute myocardial ischemia. High-yield rule: Troponin elevation = myocardial injury. Troponin elevation + evidence of acute ischemia = myocardial infarction. Sex-specific troponin thresholds receive more emphasis The Fifth Universal Definition supports sex-specific 99th percentile upper reference limits for cardiac troponin where validated assays provide them. The rationale is to reduce systematic under-recognition of myocardial injury and MI in women when a single universal threshold is used. MINOCA has also changed The document updates the terminology around MINOCA to “myocardial injury with non-obstructive coronary arteries,” emphasizing that a non-obstructive angiogram is a starting point for investigation rather than a final mechanism. Further testing may identify infarction, myocarditis, Takotsubo syndrome or another cause of injury. Old versus new: rapid revision table Older framework 2026 framework Core idea Type 1 MI Primary MI Spontaneous acute coronary pathology Type 2 MI Secondary MI Supply-demand imbalance due to another acute condition Type 3 MI Removed as a separate label Classify by clinical setting if MI likely caused death Type 4 / 5 MI Procedure-related MI Complication of PCI or cardiac surgery with objective evidence What changes for exam preparation? Do not rely only on the old numerical labels if a question explicitly asks about the 2026 Fifth Universal Definition. Primary MI is broader than old type 1 MI; it includes acute coronary mechanisms beyond atherothrombosis. Secondary MI is supply-demand imbalance caused by another acute condition. Procedure-related MI replaces the old type 4/5 structure for contemporary classification. Type 3 MI is no longer a separate category. Always distinguish myocardial injury from infarction: ischemia is the deciding concept. Frequently Asked Questions Are Type 1, 2, 3, 4 and 5 MI completely “wrong” now? They belong to the older Fourth Universal Definition framework. The 2026 Fifth Universal Definition replaces the numerical clinical classification with primary, secondary and procedure-related MI. Does every elevated troponin mean MI? No. Elevated troponin means myocardial injury. MI requires acute myocardial injury plus evidence of acute ischemia. What replaces Type 2 MI? Secondary myocardial infarction. What replaces Type 4 and Type 5 MI? Procedure-related myocardial infarction. What is the easiest memory trick? Primary = coronary problem. Secondary = another acute illness creates supply-demand imbalance. Procedure-related = complication of PCI or cardiac surgery.   Authoritative Sources American Heart Association — Fifth Universal Definition of Myocardial Infarction (2026) European Heart Journal — Fifth Universal Definition of Myocardial Infarction (2026) American College of Cardiology — summary of the 2026 Universal Definition   Medical disclaimer: This article is for medical education and does not replace individualized diagnosis or treatment decisions.

Medical, Medicine, Medicine classes

Pirtobrutinib Moves to First-Line Therapy

A drug that entered the CLL story as a rescue option after prior BTK therapy has now crossed a major line: pirtobrutinib is now FDA-approved for previously untreated CLL/SLL in adults without a known 17p deletion. The October 2, 2026 approval is based on the phase 3 BRUIN CLL-313 trial and makes the non-covalent BTK inhibitor relevant at the very start of the treatment pathway. Bottom line: Pirtobrutinib is no longer only a later-line CLL drug. In the newly approved population, it can be used as first-line therapy, and the phase 3 trial showed a marked progression-free survival advantage over bendamustine plus rituximab.   What exactly did the FDA approve? On October 2, 2026, the U.S. FDA approved pirtobrutinib (Jaypirca) for adults with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) with no known deletion of chromosome 17p. The approval was supported by BRUIN CLL-313, a randomized open-label phase 3 study. This wording matters. The approval is not a blanket “all untreated CLL” label. The pivotal trial excluded patients with known del(17p), a biologically high-risk group in which treatment selection remains especially dependent on molecular risk and contemporary guideline pathways. BRUIN CLL-313: the result students and clinicians should remember Population: 282 adults with previously untreated CLL/SLL and no known del(17p). Intervention: pirtobrutinib given until disease progression or unacceptable toxicity. Comparator: bendamustine plus rituximab for six cycles. Primary efficacy endpoint: progression-free survival assessed by independent review. At an estimated median PFS follow-up of 28 months, median PFS was not estimable in the pirtobrutinib arm versus 33.5 months with bendamustine-rituximab. Hazard ratio for progression or death: 0.20 (95% CI 0.11–0.37; p<0.0001) in the FDA summary. Exam memory line: BRUIN CLL-313 = untreated CLL/SLL, no known del(17p), pirtobrutinib versus bendamustine-rituximab, major PFS benefit. Why is pirtobrutinib different from older BTK inhibitors? Ibrutinib, acalabrutinib and zanubrutinib are covalent BTK inhibitors. They bind irreversibly to BTK at cysteine 481. Pirtobrutinib is a highly selective, reversible non-covalent BTK inhibitor. It can inhibit BTK without depending on that covalent C481 bond, which is one reason it became important in patients whose disease had progressed after a covalent BTK inhibitor. The biological concept is high yield: resistance to covalent BTK inhibition can emerge through changes in BTK itself or in downstream signaling. A non-covalent inhibitor uses a different binding strategy and can retain activity in some settings in which a prior covalent inhibitor has failed. Does this mean chemotherapy is finished in CLL? The direction of travel is clear: modern CLL management is increasingly built around targeted therapy rather than traditional chemoimmunotherapy. However, “chemotherapy is dead” is too absolute. Treatment still depends on age, comorbidity, disease genetics, prior therapy, drug availability, patient preference, duration of therapy and regional guidelines. What the new approval does show is how rapidly CLL is moving toward pathway-directed therapy. A non-covalent BTK inhibitor has now beaten a classic bendamustine-rituximab regimen in a first-line randomized study in the approved population. What should be checked before treatment? Confirm the diagnosis and indication for starting therapy; asymptomatic early CLL is often observed rather than treated immediately. Risk-stratify with FISH/cytogenetics and TP53 assessment, particularly because del(17p)/TP53-aberrant disease changes the treatment conversation. Review previous cardiovascular history, bleeding risk, infection history, concomitant medicines and drug interactions. Discuss continuous versus time-limited approaches and patient preferences where alternatives exist. Important adverse effects and practical cautions As with other agents in the BTK pathway, clinicians should remain alert to infection, cytopenias, bleeding, rhythm disturbances and other treatment-emergent toxicities described in the prescribing information. The exact risk profile is not identical across BTK inhibitors, and treatment choice should not be made by mechanism alone. Do not overgeneralize: A new indication does not mean pirtobrutinib is automatically the best first-line choice for every patient with CLL. Molecular risk, co-morbidity, competing regimens, guideline updates and access still matter. Why this update matters for NEET PG / INI-CET / FMGE learners Know the class: pirtobrutinib = non-covalent (reversible) BTK inhibitor. Know the disease: CLL/SLL. Know the 2026 first-line update: previously untreated adults without known del(17p). Know the trial: BRUIN CLL-313. Do not confuse pirtobrutinib with covalent BTK inhibitors such as ibrutinib, acalabrutinib and zanubrutinib. Frequently Asked Questions Is pirtobrutinib a first-line CLL drug now? Yes. In October 2026 the FDA approved it for adults with previously untreated CLL/SLL without a known 17p deletion. Is pirtobrutinib a covalent BTK inhibitor? No. It is a reversible, non-covalent BTK inhibitor. What trial supported the first-line approval? BRUIN CLL-313, which compared pirtobrutinib with bendamustine plus rituximab in previously untreated CLL/SLL without known del(17p). Does this approval include known del(17p) disease? The newly approved first-line population specified no known 17p deletion. High-risk del(17p)/TP53-aberrant disease should be managed according to dedicated contemporary pathways. Can asymptomatic CLL be treated just because a new drug is available? No. Treatment is started for accepted clinical indications; many patients with early asymptomatic CLL remain under active surveillance.   Authoritative Sources S. FDA — Pirtobrutinib approval for previously untreated CLL/SLL (Oct 2, 2026) gov — BRUIN CLL-313 (NCT05023980) Medical disclaimer: This article is for medical education and does not replace individualized diagnosis or treatment decisions.

Medical, Medicine, Medicine classes

A PCSK9 Inhibitor in a Tablet? Meet Enlicitide, the New Oral Cholesterol Drug

For years, there was an easy examination question: “What is the major disadvantage of PCSK9 inhibitors?” One obvious answer was: they are injectable. Not anymore. On July 17, 2026, the US FDA approved enlicitide, marketed as Lipfendra, making it the first FDA-approved oral PCSK9 inhibitor for lowering LDL cholesterol in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH). In the pivotal clinical program, oral enlicitide produced roughly 56–59% placebo-adjusted reductions in LDL cholesterol at 24 weeks. For a once-daily tablet, that number deserves attention. HIGH-YIELD ONE-LINER: Enlicitide = first oral PCSK9 inhibitor that lowers LDL-C by 65%. WOW!   First, revise PCSK9 in 30 seconds The liver removes circulating LDL cholesterol using LDL receptors. After an LDL particle binds its receptor, the complex is internalized into the hepatocyte. Normally, the LDL receptor can be recycled back to the hepatocyte surface and used again. PCSK9 binds LDL receptors and promotes their degradation. ↑ PCSK9 → ↓ LDL receptors → ↑ circulating LDL-C Block PCSK9 → ↑ recycled LDL receptors → ↑ LDL clearance → ↓ LDL-C That is why PCSK9 became such an attractive therapeutic target. But didn’t we already have PCSK9 drugs? Yes. Alirocumab and evolocumab are monoclonal antibodies targeting PCSK9 and are administered subcutaneously. Inclisiran approaches the pathway differently: it uses small-interfering RNA to reduce hepatic PCSK9 synthesis and is also injectable. The conceptual change with enlicitide is simple: PCSK9 lowering has entered the tablet era. How effective is enlicitide? The FDA approval was supported by randomized, double-blind, placebo-controlled studies in adults with hypercholesterolemia receiving background lipid-lowering therapy. The primary efficacy measure was percentage change in LDL-C at week 24. Population Approx. baseline LDL-C Placebo-adjusted LDL-C reduction at week 24 ASCVD/high cardiovascular risk 96 mg/dL ~56% Heterozygous familial hypercholesterolemia 119 mg/dL ~59% These are substantial LDL reductions and explain why an oral PCSK9 inhibitor has generated considerable clinical interest. The CORALreef story In the Phase 3 CORALreef Lipids study, nearly all participants were receiving statins. At week 24, LDL-C fell markedly with enlicitide while remaining essentially unchanged in the placebo group. Enlicitide also reduced non-HDL cholesterol, apolipoprotein B and lipoprotein(a). The key teaching point is that enlicitide was not developed simply as a replacement for statins in untreated patients. It is a potent additional LDL-lowering option for patients who remain above their recommended LDL level despite background therapy. How does it compare with other oral non-statin drugs? The CORALreef AddOn study provided a useful short-term comparison in statin-treated patients whose LDL remained above target. At day 56, the reported mean LDL-C reductions were approximately: Treatment Approx. LDL-C reduction Enlicitide 65% Ezetimibe 28% Bempedoic acid 6% Bempedoic acid + ezetimibe 37% These are lipid-efficacy comparisons over a relatively short period, not comparisons of cardiovascular outcomes. They nevertheless illustrate the potency of oral PCSK9 inhibition. Does enlicitide replace statins? No. Statins remain foundational therapy for LDL lowering and cardiovascular risk reduction in appropriate patients. The more useful clinical question is what to add when statin therapy does not lower LDL sufficiently, or when treatment needs to be individualized because of tolerance, risk, access or other clinical considerations. Depending on the patient, non-statin options may include ezetimibe, bempedoic acid and PCSK9-directed therapies. Why 2026 is a big year for LDL management The 2026 ACC/AHA dyslipidemia guideline also updated the way clinicians think about lipid management, including explicit LDL-C goals and use of PREVENT-ASCVD equations for primary-prevention risk assessment. Borderline/intermediate-risk primary prevention: LDL-C <100 mg/dL High-risk primary prevention: LDL-C <70 mg/dL Very-high-risk ASCVD: LDL-C <55 mg/dL Very-high-risk ASCVD → think LDL-C <55 mg/dL. The guideline also emphasizes measuring lipoprotein(a), or Lp(a), at least once in adulthood. Together, the new guideline and the arrival of an oral PCSK9 inhibitor make lipid management one of the most important cardiovascular update areas of 2026. Is enlicitide safe? Across the major studies, overall adverse-event rates were broadly comparable between enlicitide and placebo. Reported adverse reactions included symptoms such as diarrhea and dizziness in relevant study populations. As with any newly introduced therapy, prescribing should follow the approved product information and the patient’s individual clinical context. A new drug should not be prescribed merely because an LDL value is elevated. Absolute cardiovascular risk, LDL level, prior therapy, tolerability, comorbidities and current guideline recommendations remain central. The limitation every doctor should understand Enlicitide has demonstrated powerful LDL lowering. But lowering LDL in a lipid-efficacy trial and directly demonstrating fewer myocardial infarctions, strokes or cardiovascular deaths are not identical endpoints. The pivotal studies established strong lipid effects. Long-term cardiovascular outcome evidence will be important in defining the drug’s ultimate place in preventive cardiology. The scientifically correct message today is: enlicitide markedly lowers LDL; the magnitude of its eventual cardiovascular-outcome benefit should be judged from dedicated outcome evidence. NEET-PG / INI-CET / FMGE Exam Box A patient with hypercholesterolemia is prescribed the first FDA-approved oral inhibitor of PCSK9. Which drug has been prescribed? Inclisiran Evolocumab Enlicitide Alirocumab Answer: C. Enlicitide Make these associations automatic: Enlicitide → oral PCSK9 inhibitor Evolocumab / Alirocumab → monoclonal antibodies against PCSK9 Inclisiran → siRNA → decreases hepatic PCSK9 synthesis The bigger story This is not simply another cholesterol tablet. For years, PCSK9-directed treatment meant an injection. Enlicitide changes that practical assumption. Whether oral administration substantially expands PCSK9 use will depend on cardiovascular outcome evidence, long-term safety, cost, availability and real-world adherence. But one fact has already changed: PCSK9 inhibition is no longer an injection-only strategy. And that is precisely the kind of update that separates current clinical medicine from an outdated textbook. Keep Hammering. Frequently Asked Questions What is the first oral PCSK9 inhibitor? Enlicitide (Lipfendra) is the first FDA-approved oral PCSK9 inhibitor. It was approved in July 2026 for adults with hypercholesterolemia, including HeFH. How much does enlicitide lower LDL cholesterol? Pivotal studies reported placebo-adjusted LDL-C reductions of roughly 56% at week 24 in an ASCVD/high-risk population and roughly 59% in patients with HeFH. Is enlicitide an injection? No. Enlicitide is an oral once-daily therapy, distinguishing it from previously approved injectable PCSK9-directed treatments. […]

Scroll to Top